tiprankstipranks
Advertisement
Advertisement

DE:JNJ Stock Latest News

Kennedy driving vast vaccine inquiry despite toned-down criticism, NYT says
The FlyKennedy driving vast vaccine inquiry despite toned-down criticism, NYT says
16h ago
AZN
BMY
Psychedelic: Jefferies initiates Compass Pathways with a Buy rating
PremiumThe Fly
Psychedelic: Jefferies initiates Compass Pathways with a Buy rating
5d ago
JNJ
CMND
FDA blocked publication of studies showing Covid vaccine safe, NYT says
PremiumThe Fly
FDA blocked publication of studies showing Covid vaccine safe, NYT says
7d ago
AZN
BMY
Trump Trade: Microsoft, Google agree to U.S. security reviews of AI models
PremiumThe Fly
Trump Trade: Microsoft, Google agree to U.S. security reviews of AI models
7d ago
AZN
BMY
Johnson & Johnson announces results from Phase 3 FUZION study of tremfya
PremiumThe Fly
Johnson & Johnson announces results from Phase 3 FUZION study of tremfya
7d ago
JNJ
Johnson & Johnson announces Phase 2b data from JNJ-4804 studies
PremiumThe FlyJohnson & Johnson announces Phase 2b data from JNJ-4804 studies
7d ago
JNJ
Johnson & Johnson announces study of OTTAVA System met primary endpoints
Premium
The Fly
Johnson & Johnson announces study of OTTAVA System met primary endpoints
7d ago
JNJ
Nanobiotix announces FDA acceptance of NANORAY-312 study protocol amendment
Premium
The Fly
Nanobiotix announces FDA acceptance of NANORAY-312 study protocol amendment
8d ago
JNJ
NBTX
Johnson & Johnson’s Caplyta shows greater efficacy in major depressive disorder
PremiumThe Fly
Johnson & Johnson’s Caplyta shows greater efficacy in major depressive disorder
8d ago
JNJ
Compass Pathways initiated with a Buy at Jefferies
PremiumThe Fly
Compass Pathways initiated with a Buy at Jefferies
9d ago
JNJ
CMPS
Halozyme names Darren Snellgrove as CFO
PremiumThe Fly
Halozyme names Darren Snellgrove as CFO
12d ago
JNJ
HALO
Johnson & Johnson appoints Koors as Vice President, Investor Relations
PremiumThe Fly
Johnson & Johnson appoints Koors as Vice President, Investor Relations
12d ago
JNJ
Underappreciated Autoimmune Franchise Potential Keeps Johnson & Johnson at Buy with Unchanged $275 Price Target
PremiumRatingsUnderappreciated Autoimmune Franchise Potential Keeps Johnson & Johnson at Buy with Unchanged $275 Price Target
13d ago
JNJ
Johnson & Johnson Shareholders Back Board, Pay at 2026 Meeting
Premium
Company Announcements
Johnson & Johnson Shareholders Back Board, Pay at 2026 Meeting
14d ago
8K
JNJ
Johnson & Johnson’s Imaavy granted Priority Review by FDA in hemolytic anemia
Premium
The Fly
Johnson & Johnson’s Imaavy granted Priority Review by FDA in hemolytic anemia
15d ago
JNJ
AbbVie price target lowered to $294 from $299 at Piper Sandler
PremiumThe Fly
AbbVie price target lowered to $294 from $299 at Piper Sandler
19d ago
JNJ
ABBV
Johnson & Johnson reports new data from Phase 3 Vivacity-MG3 study
PremiumThe Fly
Johnson & Johnson reports new data from Phase 3 Vivacity-MG3 study
20d ago
JNJ
MeiraGTx price target raised to $30 from $26 at Piper Sandler
PremiumThe Fly
MeiraGTx price target raised to $30 from $26 at Piper Sandler
20d ago
JNJ
MGTX
Johnson & Johnson receives European CE Mark approval for Ethicon 4000 Stapler
PremiumThe Fly
Johnson & Johnson receives European CE Mark approval for Ethicon 4000 Stapler
20d ago
JNJ
Johnson & Johnson to showcase electrophysiology portfolio at HRS meeting
PremiumThe FlyJohnson & Johnson to showcase electrophysiology portfolio at HRS meeting
21d ago
JNJ
Johnson & Johnson price target raised to $266 from $244 at Guggenheim
Premium
The Fly
Johnson & Johnson price target raised to $266 from $244 at Guggenheim
22d ago
JNJ
Johnson & Johnson price target raised to $266 from $244 at Guggenheim
Premium
The Fly
Johnson & Johnson price target raised to $266 from $244 at Guggenheim
22d ago
JNJ

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >